• Profile
Close

The new surveillance, epidemiology, and end results prostate with watchful waiting database: Opportunities and limitations

European Urology Jan 25, 2020

Jeong CW, et al. - Researchers sought to present a comprehensive description of this dataset and investigate possible biases due to missing data. In the USA, the Surveillance, Epidemiology, and End Results (SEER) is a population-based epidemiologic registry. They distinguished a total of 316,724 individuals in the entire cohort and 257,060 men with clinically localized prostate cancer (PCa) (T1-2N0M0). They assessed the degree of missing data for each variable. They correlated two versions of the data: one that excluded cases with missing data and one dataset generated applying multiple imputations to examine possible bias due to missing data for cancer characterization. Moreover, while the SEER Prostate with the WW dataset allows a new approach to defining treatment trends for men with PCa, including the use of AS/WW, the amount of missing data should not be overlooked.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay